AOD 9604 ZPHC — 12.5 mg

AOD 9604 — targeted fat-loss peptide
5 lyophilised vials × 2.5 mg (total 12.5 mg)

• Mechanism: fragment 176-191 analogue that boosts lipolysis and blocks lipogenesis without raising IGF-1 or blood glucose.
• Reconstitution: add 1 ml bacteriostatic water → 2.5 mg/ml; swirl gently, do not shake.
• Storage: refrigerate 2 – 8 °C after mixing; freeze-dried powder ships safely at room temperature.
• Sample research dosing: 250 – 500 µg sub-Q daily (split AM/PM) for 4 – 6 weeks.
• QC: ≥ 99 % purity (HPLC); endotoxin < 0.03 EU/mg; scratch-code authenticity on every box.
• Cold-chain packed • tamper-evident vials • discreet, tracked worldwide delivery.
  
  

  ⚗️ Handling & Storage

  • Store lyophilized powder in a cool, dry place

  • After reconstitution, refrigerate at 2–8 °C (do not freeze)

  • For research use only — not approved for human consumption
    
    

    Parameter	Standard Range	Notes
    Dose	200–500 mcg per injection	Adjusted based on study design
    Frequency	Daily	Supports steady peptide activity
    Cycle Length	8-16weeks	Often followed by off‑cycle period
    Administration	Subcutaneous injection after reconstitution	Allows controlled peptide delivery
    Timing	Morning or pre‑training	Aligns with natural metabolic activity windows